These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 24054864
21. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma. Meskawi M, Becker A, Bianchi M, Trinh QD, Roghmann F, Tian Z, Graefen M, Perrotte P, Karakiewicz PI, Sun M. Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700 [Abstract] [Full Text] [Related]
22. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era. Culp SH, Karam JA, Wood CG. Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415 [Abstract] [Full Text] [Related]
23. Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis. Gandaglia G, Bianchi M, Trinh QD, Becker A, Larouche A, Abdollah F, Roghmann F, Tian Z, Shariat SF, Briganti A, Montorsi F, Karakiewicz PI, Sun M. Int J Urol; 2014 Mar; 21(3):249-56. PubMed ID: 24033809 [Abstract] [Full Text] [Related]
24. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project. Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912 [Abstract] [Full Text] [Related]
25. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis. O'Malley RL, Hayn MH, Brewer KA, Underwood W, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T. World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189 [Abstract] [Full Text] [Related]
27. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Capitanio U, Zini L, Perrotte P, Shariat SF, Jeldres C, Arjane P, Pharand D, Widmer H, Péloquin F, Montorsi F, Patard JJ, Karakiewicz PI. Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207 [Abstract] [Full Text] [Related]
28. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis. Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK. Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403 [Abstract] [Full Text] [Related]
30. Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort. Trinh QD, Schmitges J, Bianchi M, Sun M, Shariat SF, Sammon J, Jeldres C, Zorn K, Sukumar S, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. BJU Int; 2012 Jul; 110(2 Pt 2):E21-7. PubMed ID: 22044638 [Abstract] [Full Text] [Related]
31. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, Bertini R, Karakiewicz PI. Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745 [Abstract] [Full Text] [Related]
33. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R. Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684 [Abstract] [Full Text] [Related]
34. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma. Baillargeon-Gagné S, Jeldres C, Lughezzani G, Sun M, Isbarn H, Capitanio U, Shariat SF, Crépel M, Alasker A, Widmer H, Arjane P, Patard JJ, Perrotte P, Montorsi F, Graefen M, Karakiewicz PI. BJU Int; 2010 Feb; 105(3):359-64. PubMed ID: 20089096 [Abstract] [Full Text] [Related]